article thumbnail

Balancing Innovation and Safety: The Tepezza Lawsuit’s Implications for the Pharmaceutical Industry

Strategy Driven

The mere onset of an unknown medical condition has the pharmaceutical giants leaving no stone unturned to deliver the antidotes as fast as they can. In this blog post, we will shed light on the concerns surrounding Tepezza and what it means for the ever-growing pharmaceutical industry.

article thumbnail

A New Generation of Drug Therapies Requires New Business Strategies

Harvard Business Review

The shift to advanced therapeutic modalities (ATMs) promises to change the nature of competition in the pharmaceuticals industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merck Life Sciences banks on RPA to streamline regulatory compliance

CIO

The pharmaceutical industry is a highly regulated one, especially for multinationals doing business across the globe. Merck Life Sciences, a leading chemical and pharmaceutical company, with 60,000 employees working across 66 countries, was one of them. Dependency on human resources is both time-consuming and fraught with errors.

article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

A solid grasp of the latest advancements across biotechnology, pharmaceuticals, and medical devices is essential in driving innovations and the ability to synthesize information and translate it into actionable strategies quickly. This ability to bridge the gap between science and strategy is crucial in such a highly dynamic space.

Biotech 166
article thumbnail

How API-led modernization can transform research and development at pharmaceutical companies

Capgemini

According to MuleSoft’s annual Connectivity Benchmark Report , 89% of IT leaders say data silos are an obstacle to digital transformation, and pharmaceutical companies are no strangers to this issue. However, in many cases, pharmaceutical companies rely on legacy systems that aren’t API-enabled. APIs are one key way to do this.

article thumbnail

Women IT leaders take center stage

CIO

Cultivating visibility matters for a few reasons,” says Kathryn Guarini, a former IBM CIO and now a board member at Regeneron Pharmaceuticals. Kathryn Guarini, board member, Regeneron Pharmaceuticals, and former IBM CIO Guarini “You want to be the one considered for opportunities to have an impact,” she says.

article thumbnail

The ‘Great Retraining’: IT upskills for the future

CIO

“It’s a win-win when you can get the long-term vision and growth of a company tied to individual career and professional development,” says Mark Yunger, vice president, head of IT at Servier Pharmaceuticals. From an individual’s perspective, it keeps careers interesting and helps people grow with the organization.